Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

Here are five points:

1. B. Riley researchers estimate Mazor will see second quarter 2018 earnings of $0.13 EPS; third quarter 2018 earnings of $0.12 EPS; and fourth quarter 2018 earnings of $0.07 EPS.

2. The firm has a "neutral" rating on Mazor with a $25 price objective.

3. Mazor has a 52-week low of $9.16 and 52-week high of $26.55.

4. The company's 50-day moving average is $22.62, with a 200-day moving average of $22.74.

Here are four insights:

1. The increasing importance of data-driven information is attracting the emergence of technology giants.

2. The larger technology organizations offer their experience in dealing with information issues in other industries.

3. Industry experts foresee consolidation activity as more HIT startups enter the scene. Where smaller companies can zone in on a trend, larger companies can provide the customer base.

4. Technology companies will reap benefits by focusing on user experience, from reducing wait times to ensuring privacy.

Here are five key notes:

1. The 4D Health Approach is holistic and takes into consideration a patient's overall health, ailments, environment and future aspirations.

2. Specifically, the approach addresses nutrition, exercise and supplementation to shorten recovery, improve wound healing and enhance strength following surgery.

3. Dr. Lanman uses the Prestige LP artificial disc, composed of titanium-ceramic composite, for disc replacement procedures.

4. Dr. Lanman served as the principal investigator on the FDA trial testing the Prestige LP disc, which was approved for one or two adjacent levels in the cervical spine in 2016.

Transparency Market Research Report Added "Regenerative Medicine Market" to its database.Albany, NY -- (SBWIRE) -- 03/03/2017 -- Regenerative medicine is an emerging field in the healthcare industry concerned with the repair, replacement, and regeneration of damaged human tissue and organs. This includes damage from age-related degeneration, congenital defects, accidents, or diseases. Due to its vital contribution, regenerative medicine is becoming widely popular in the treatment of neurological, cardiovascular, musculoskeletal, and orthopedic conditions. Bone and joint conditions are among the leading applications of regenerative medicine. The viability of several synthetic alternatives to bones and joints is one of the key points that have driven investment in regenerative medicine in the recent past.

NEW DELHI: Hospitals, nursing homes and clinics that implant cardiac stents cannot claim margins on the life-saving devices, says the government. The decision is expected to break the nexus between manufacturers, doctors and hospitals that have led to "unethical" markups in the prices of these stents.

A cardiac stent is a wire mesh tube used to clear blockages in coronary arteries and prevent heart attacks.

The National Pharmaceutical Pricing Authority on February 14 slashed stent prices by over 75%. Including VAT, drug eluting stents (DES) and bioresorbable vascular scaffolds (BVS) will now only cost heart patients Rs 31,080, while bare metal stents (BMS) would cost Rs 7,623.

The global spinal implants and spinal devices market is growing, due to increasing demand for minimally invasive surgeries, increasing number of hospitals and surgical centers, and commercial applications in areas, such as nucleus arthroplasty, stem cell technology and artificial disk replacement. The spinal fusion and fixation technology dominates the market and the non-fusion/ motion preservation technology segment is expected to grow with the fastest rate during the forecast period, due to increasing demand for minimally invasive surgical procedures among patients and development of technologically advanced non-fusion devices.

The massive unexplored market in the spinal implants and spinal devices industry of the developing economies is creating abundant growth opportunities for the global spinal implants and spinal devices surgery market.